Drug Delivery

Springboard’s role in MDR compliance for a new cancer treatment device

A revolutionary cancer treatment device is currently under development by one of our clients, offering a new, more targeted mode of action than existing options on the market. By precisely focusing on affected areas, this technology has the potential to deliver improved outcomes and quality of life for patients around the world. The client intends to release the device on the European market, meaning they must comply with the MDR.

Demonstrating compliance with the MDR is an essential – and often challenging – step for any device aiming for the European market. Creating the required documentation for MDR compliance demands specialist knowledge and significant time investment. It involves translating technical innovation into rigorous, structured evidence that satisfies regulatory expectations. For many organisations, especially when developing novel technologies, this process can become a major barrier to market entry.

This is where Springboard’s expertise makes a difference. With years of experience in  developing medical devices and the required supporting documentation, we help bridge the gap between ground breaking innovation and successful market access.

As part of our client’s preparations for pre-clinical trials, a crucial step on the device’s journey to market, Springboard was engaged to produce an MDR General Safety and Performance Requirements (GSPR) checklist for the device. This checklist is a key component of the technical documentation that the client’s notified body will review. Without it, the pre-clinical trial – and thus the entire development timeline – could be delayed.

The GSPR checklist demonstrates how the manufacturer intends to show compliance with each requirement and where documentation of this is held. By carefully crafting this document, we helped our client identify any gaps in their documentation and analysis whilst building a strong foundation in preparation for review by their notified body, facilitating smoother progress through the clinical trial approval process.

Supporting our client in this way is about more than just ticking regulatory boxes – it’s about contributing to the successful development of a novel and potentially lifesaving cancer treatment. We are proud to play our part in advancing technology that could offer new hope to patients worldwide.

At Springboard, we understand that innovation deserves expert support. If you’re developing a medical device and facing the complexities of MDR compliance, we’re ready to help you navigate the path to market success. Get in touch today.

Talk to an Expert

Ready to take the next step in product development? Connect with the Gilero team to explore tailored solutions—from concept through commercialization.

Gilero News

Gilero, a Sanner Group Company, starts manufacturing in Greensboro, USA

Life at Gilero

Completing a Graduate Degree while Working at Gilero

Manufacturing

The Importance of Current Good Manufacturing Practices (cGMPs) in Medical Device Manufacturing

General

Heuristic Analysis: An Alternative to Formative Usability Testing  

Gilero News

Sanner Group Acquires Gilero to Expand its Global Medical Device Offering

Drug Delivery

Developing a Simpler Nasal Vaccine Administration Device for Infants

Drug Delivery

Beyond Borders: How geopolitical shifts are redefining pharma and medical device development